COVID-19 set back Alzheimer’s disease research
AuntMinnie
FEBRUARY 5, 2024
U.S. Alzheimer’s disease (AD) research centers saw a 77% drop in participants enrolling in clinical trials due to the COVID-19 pandemic, according to a study conducted by epidemiologists at the University of Pittsburgh. Notably, the effect was experienced most keenly by historically underserved populations, with a 91% drop in Black/African American participants compared with 71% in white participants, wrote lead author Elizabeth Shaaban, PhD, of the school’s Alzheimer's Disease Research Center (
Let's personalize your content